NasdaqGM - Delayed Quote • USD
CRISPR Therapeutics AG (CRSP)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 7:59 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BOLZON BRADLEY J Director | Sale | Jul 19, 2021 | -- |
| GEORGE SIMEON J. Director | Stock Award(Grant) | Feb 27, 2024 | -- |
| HO TONY W Officer | Conversion of Exercise of derivative security | Dec 3, 2021 | 52,364 |
| KASINGER JAMES R. General Counsel | Sale | Mar 12, 2024 | 61,174 |
| KLEIN LAWRENCE OTTO Chief Operating Officer | Conversion of Exercise of derivative security | Mar 11, 2022 | 26,797 |
| KULKARNI SAMARTH Chief Executive Officer | Sale | Mar 15, 2024 | 408,122 |
| MORROW PHUONG KHANH Officer | Conversion of Exercise of derivative security | May 23, 2023 | 4,411 |
| PRASAD RAJU Chief Financial Officer | Sale | Mar 15, 2024 | 6,476 |
| SMITH BRENDAN Chief Financial Officer | Conversion of Exercise of derivative security | Feb 17, 2023 | 5,072 |
| TOMSICEK MICHAEL JOHN Chief Financial Officer | Sale | Aug 6, 2021 | 1,891 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
21.32
-0.84%
VRTX Vertex Pharmaceuticals Incorporated
393.48
+0.10%
EDIT Editas Medicine, Inc.
5.55
-1.07%
VKTX Viking Therapeutics, Inc.
64.67
-2.71%
BEAM Beam Therapeutics Inc.
24.31
0.00%
DNA Ginkgo Bioworks Holdings, Inc.
0.9246
+6.08%
BLUE bluebird bio, Inc.
0.9530
-1.07%
RXRX Recursion Pharmaceuticals, Inc.
7.40
-0.94%
IOVA Iovance Biotherapeutics, Inc.
11.72
-0.68%
MRNA Moderna, Inc.
102.00
-1.39%